Drugs for Kidney Diseases
Although medicine cannot reverse chronic kidney disease, it is often used to help treat symptoms and complications and to slow further kidney damage. Most people who have chronic kidney disease have problems with high blood pressure at some time during their disease. Medicines that lower blood pressure help to keep it in a target range and stop any more kidney damage. You may need to try several blood pressure medicines before you find the medicine that controls your blood pressure well without bothersome side effects. Most people need to take a combination of medicines to get the best results. Your doctor may order blood tests 3 to 5 days after you start or change your medicines. The tests help your doctor make sure that your medicines are working correctly.
Medicines may be used to treat symptoms and complications of chronic kidney disease. These medicines include:
Erythropoietin (rhEPO) therapy and iron replacement therapy (iron pills or intravenous iron) for anaemia.
Medicines for electrolyte imbalances.
Diuretics to treat fluid buildup caused by chronic kidney disease.
ACE inhibitors and ARBs. These may be used if you have protein in your urine (proteinuria) or have heart failure. Regular blood tests are required to make sure that these medicines don't raise potassium levels (hyperkalemia) or make kidney function worse.
Both erythropoietin (rhEPO) therapy and iron replacement therapy may also be used during dialysis to treat anemia, which often develops in advanced chronic kidney disease.
Erythropoietin (rhEPO) stimulates the production of new red blood cells and may decrease the need for blood transfusions. This therapy may also be started before dialysis is needed, when anemia is severe and causing symptoms.
Iron therapy can help increase levels of iron in the body when rhEPO therapy alone is not effective.
Vitamin D helps keep bones strong and healthy
Related Conference of Drugs for Kidney Diseases
7th International Conference on Clinical Immunology, Neuropharmacology and Drug Development
Drugs for Kidney Diseases Conference Speakers
Recommended Sessions
- Kidney Cancer
- Glomerular Disorders
- Hypertensive Associated Kidney Diseases
- Kidney Diseases & Diagnosis of Kidney Diseases
- Metabolic, Fluid & Electrolyte disorders
- Nephritis & Onconephrology
- Renal Pathology-Immunology
- Urology/Urinary tract infections
- Acute Kidney Injury
- Cardiovascular Impacts of Kidney Disease
- Clinical Nephrology
- commercialization
- Diabetic Nephropathy
- Dialysis
- Drugs for Kidney Diseases
- End Stage Renal diseases & Chronic Kidney Diseases
- Geriatric Nephrology
- Kidney and Bladder stones
- Kidney Transplantation
- Nephrology
- Nephrology Nursing
- Pediatric Nephrology
- Renal Nutrition & Metabolism
- Tubular and Interstitial Diseases
Related Journals
Are you interested in
- Acute Kidney Injury - Kidney Care 2026 (UK)
- Acute Kidney Injury (AKI) - Nephrology 2025 (France)
- Advanced Imaging Techniques in Neuropharmacology - Neuropharmacology 2025 (Italy)
- Advances in Immuno-Oncology for CNS Tumors - Neuropharmacology 2025 (Italy)
- Advances in Kidney Transplantation - Nephrologists 2025 (France)
- AI-Driven Drug Discovery in Neuropharmacology - Neuropharmacology 2025 (Italy)
- Artificial Intelligence (AI) and Digital Health in Nephrology - Nephrology 2025 (France)
- Artificial Intelligence and Machine Learning in Renal Diagnostics - EURO NEPHROLOGY 2025 (Italy)
- Artificial Intelligence in Nephrology - World Nephrology 2026 (Netherlands)
- Autoimmune Kidney Diseases - Nephrology 2025 (France)
- Autoimmunity and Neuropharmacology: New Insights - Neuropharmacology 2025 (Italy)
- Biomarkers and Molecular Mechanisms in Renal Diseases - Nephrology 2025 (France)
- Biomarkers in Kidney Disease - KIDNEY MEET 2025 (UK)
- Biomarkers in Neuroimmune and Neuroinfectious Diseases - Neuropharmacology 2025 (Italy)
- Blood-Brain Barrier: Challenges and Solutions - Neuropharmacology 2025 (Italy)
- Cardio-Renal Syndrome - World Nephrology 2026 (Netherlands)
- Cardiovascular Impact of Kidney Disease - KIDNEY MEET 2025 (UK)
- Cell-Based Therapies in Neuroimmune Disorders - Neuropharmacology 2025 (Italy)
- Challenges in Paediatric Nephrology - Nephrologists 2025 (France)
- Chronic Kidney Disease - KIDNEY MEET 2025 (UK)
- Chronic Kidney Disease (CKD) - Nephrology 2025 (France)
- Chronic Kidney Disease (CKD): Global Epidemiology & Prevention - World Nephrology 2026 (Netherlands)
- Chronic Kidney Disease and Diabetes - Nephrologists 2025 (France)
- Clinical Nephrology - Kidney Care 2026 (UK)
- Clinical Trails in Kidney Therapy - Nephrologists 2025 (France)
- Clinical Trials and Research in Nephrology - Nephrology 2025 (France)
- Clinical Trials in Neuroimmunology - Neuropharmacology 2025 (Italy)
- CRISPR Innovations for Kidney Disorders - EURO NEPHROLOGY 2025 (Italy)
- Critical Care Nephrology - KIDNEY MEET 2025 (UK)
- Diabetic Nephropathy - KIDNEY MEET 2025 (UK)
- Diabetic Nephropathy - Kidney Care 2026 (UK)
- Diabetic Nephropathy and Metabolic Syndrome - Nephrology 2025 (France)
- Dialysis - KIDNEY MEET 2025 (UK)
- Dialysis – Hemodialysis and Peritoneal Dialysis - Nephrology 2025 (France)
- Digital Health Innovations and Biomarker Development - EURO NEPHROLOGY 2025 (Italy)
- Drugs for Kidney Disease - KIDNEY MEET 2025 (UK)
- Drugs for Kidney Diseases - Kidney Care 2026 (UK)
- Emerging Biomarkers in Nephrology - Nephrologists 2025 (France)
- Emerging Neuroprotective Agents - Neuropharmacology 2025 (Italy)
- Emerging Therapies for Polycystic Kidney Disease - EURO NEPHROLOGY 2025 (Italy)
- Environmental and Occupational Nephrology - World Nephrology 2026 (Netherlands)
- Environmental Risk Factors and Kidney Disease - EURO NEPHROLOGY 2025 (Italy)
- Epidemiology and the Global Burden of Kidney Diseases - Nephrology 2025 (France)
- Epigenetic Modulation in Neuroimmune Disorders - Neuropharmacology 2025 (Italy)
- Ethical and Regulatory Considerations in Neuropharmacology - Neuropharmacology 2025 (Italy)
- Ethical, Legal, and Policy Issues - Nephrology 2025 (France)
- Ethics and Policy in Renal Medicine - EURO NEPHROLOGY 2025 (Italy)
- Ethics in Kidney Donation and Transplantation - Nephrologists 2025 (France)
- Ethics in Kidney Transplantation - EURO NEPHROLOGY 2025 (Italy)
- Fluid and Electrolyte Disorders in Nephrology - EURO NEPHROLOGY 2025 (Italy)
- Gene Therapy and CRISPR in Neuroimmunology - Neuropharmacology 2025 (Italy)
- Genetic and Rare Kidney Disorders - World Nephrology 2026 (Netherlands)
- Genetics and Hereditary Renal Disorders - Nephrology 2025 (France)
- Genetics of Kidney Disease - Nephrologists 2025 (France)
- Geriatric Nephrology - Kidney Care 2026 (UK)
- Geriatric Nephrology and Aging Populations - EURO NEPHROLOGY 2025 (Italy)
- Geriatric Nephrology: Managing the Aging Kidney - World Nephrology 2026 (Netherlands)
- Global Perspectives on kidney Health - Nephrologists 2025 (France)
- Glomerular and Tubulointerstitial Diseases - Nephrology 2025 (France)
- Glomerular Diseases and Management - World Nephrology 2026 (Netherlands)
- Hypertension & Kidney Health - World Nephrology 2026 (Netherlands)
- Hypertension and Renal Vascular Disorders - Nephrology 2025 (France)
- Hypertension effect on kidney - KIDNEY MEET 2025 (UK)
- Immunology and Inflammatory Kidney Diseases - Nephrology 2025 (France)
- Immunomodulation and Targeted Therapies for Glomerular Diseases - EURO NEPHROLOGY 2025 (Italy)
- Immunomodulation in Stroke and Traumatic Brain Injury - Neuropharmacology 2025 (Italy)
- Infection and Immunity in Renal Diseases - World Nephrology 2026 (Netherlands)
- Infections and Renal Complications - Nephrology 2025 (France)
- Innovations in Dialysis Techniques - Nephrologists 2025 (France)
- Innovations in Home-Based Renal Therapy: Smart Dialysis Devices - EURO NEPHROLOGY 2025 (Italy)
- Innovations in Nephrology Devices and Technology - Nephrology 2025 (France)
- Innovative Approaches to Stone Disease - Nephrologists 2025 (France)
- Innovative Dialysis Modalities - World Nephrology 2026 (Netherlands)
- Integrating care for Kidney Failure - Nephrologists 2025 (France)
- Kidney and Bladder Cancer - Kidney Care 2026 (UK)
- Kidney Disease in Aging Population - Nephrologists 2025 (France)
- Kidney Diseases & Diagnosis of Kidney Diseases - Kidney Care 2026 (UK)
- Kidney Failure - KIDNEY MEET 2025 (UK)
- Kidney Health and Nutrition - Nephrologists 2025 (France)
- Kidney Stones - KIDNEY MEET 2025 (UK)
- Kidney Transplantation - KIDNEY MEET 2025 (UK)
- Kidney Transplantation - Kidney Care 2026 (UK)
- Kidney Transplantation and Organ Preservation - Nephrology 2025 (France)
- Kidney Transplantation: Advances & Ethical Considerations - World Nephrology 2026 (Netherlands)
- Kidney-on-a-Chip Technology - EURO NEPHROLOGY 2025 (Italy)
- Managing Chronic Kidney Disease - Nephrologists 2025 (France)
- Mental Health in Nephrology Patients - World Nephrology 2026 (Netherlands)
- Microbiome-Targeted Therapies in Neurology - Neuropharmacology 2025 (Italy)
- Mineral and Bone Disorder in CKD - KIDNEY MEET 2025 (UK)
- Minimally Invasive Urological surgery - Nephrologists 2025 (France)
- Molecular Mechanisms of Neuroimmune Responses - Neuropharmacology 2025 (Italy)
- Nanomedicine in Renal Therapeutics - EURO NEPHROLOGY 2025 (Italy)
- Nanotechnology in Neuropharmacology - Neuropharmacology 2025 (Italy)
- Nephrology - Kidney Care 2026 (UK)
- Nephrology and Cardiovascular Comorbidities - Nephrology 2025 (France)
- Nephrology Nursing - KIDNEY MEET 2025 (UK)
- Nephrology Nursing - Kidney Care 2026 (UK)
- Nephrology Nursing and Allied Health Roles - World Nephrology 2026 (Netherlands)
- Nephrology Nursing and Patient Care - Nephrology 2025 (France)
- Nephrotoxicity and Drug-induced Kidney Injury - Nephrology 2025 (France)
- Neuroimmune Crosstalk in Metabolic Disorders - Neuropharmacology 2025 (Italy)
- Neuroimmune Interactions in Psychiatric Disorders - Neuropharmacology 2025 (Italy)
- Neuroimmune Pathways in Pain Management - Neuropharmacology 2025 (Italy)
- Neuroinflammation: Mechanisms and Therapeutic Strategies - Neuropharmacology 2025 (Italy)
- Neuropharmacological Interventions in Neurodegenerative Disorders - Neuropharmacology 2025 (Italy)
- Neurotoxicology and Immunotoxicology - Neuropharmacology 2025 (Italy)
- Next-Generation Immunotherapies in Neurological Disorders - Neuropharmacology 2025 (Italy)
- Novel Drug Delivery Systems for Neuroimmune Agents - Neuropharmacology 2025 (Italy)
- Nutrition and Lifestyle in Kidney Health - Nephrology 2025 (France)
- Nutrition and Lifestyle in Kidney Health - World Nephrology 2026 (Netherlands)
- Nutritional Genomics and Personalized Renal Dietetics - EURO NEPHROLOGY 2025 (Italy)
- Patient-Centered Care and Advocacy - World Nephrology 2026 (Netherlands)
- Patient-Centric Kidney Care - Nephrologists 2025 (France)
- Pediatric Nephrology - Kidney Care 2026 (UK)
- Pediatric Nephrology and Developmental Disorders - EURO NEPHROLOGY 2025 (Italy)
- Pediatric Nephrology and Developmental Nephrology - Nephrology 2025 (France)
- Pediatric Nephrology: Growing Concerns in Children - World Nephrology 2026 (Netherlands)
- Pediatric Neuroimmunology: Challenges and Innovations - Neuropharmacology 2025 (Italy)
- Pediatrics and Geriatric Nephrology - KIDNEY MEET 2025 (UK)
- Personalized Medicine in Neuroimmunology - Neuropharmacology 2025 (Italy)
- Pharmacogenomics and Personalized Medicine in Renal Therapeutics - EURO NEPHROLOGY 2025 (Italy)
- Pharmacogenomics in Renal Drug Response - EURO NEPHROLOGY 2025 (Italy)
- Pharmacology and Nephrotherapeutics - Nephrology 2025 (France)
- Precision Medicine in Kidney Care - World Nephrology 2026 (Netherlands)
- Precision Neuropharmacology: From Bench to Bedside - Neuropharmacology 2025 (Italy)
- Preventing Acute Kidney Injury - Nephrologists 2025 (France)
- Psychosocial aspects of Kidney Disease - Nephrologists 2025 (France)
- Public Health and Kidney Disease Prevention - Nephrology 2025 (France)
- Regenerative Medicine and Stem Cell Therapies - World Nephrology 2026 (Netherlands)
- Regenerative Medicine and Tissue Engineering in Nephrology - EURO NEPHROLOGY 2025 (Italy)
- Regenerative Medicine in Neuropharmacology - Neuropharmacology 2025 (Italy)
- Renal Nutrition - KIDNEY MEET 2025 (UK)
- Renal Nutrition and Metabolism - Kidney Care 2026 (UK)
- Renal Oncology – Kidney Cancers and Tumors - Nephrology 2025 (France)
- Renal Pathology & Immunology - Kidney Care 2026 (UK)
- Renal Pathology and Diagnostic Imaging - Nephrology 2025 (France)
- Renal Pathology and Immunology - KIDNEY MEET 2025 (UK)
- Renal Replacement Therapy & Future Trends - Nephrology 2025 (France)
- Robotic kidney Transplantation - KIDNEY MEET 2025 (UK)
- Robotic Surgery - Kidney Care 2026 (UK)
- Role of Pharmacotherapy in Nephrology - Nephrologists 2025 (France)
- Sophisticated Imaging: 3D Mapping and Evaluation - EURO NEPHROLOGY 2025 (Italy)
- Stem Cell and Tissue Engineering in Nephrology - EURO NEPHROLOGY 2025 (Italy)
- Stem Cells in Renal Disorders - KIDNEY MEET 2025 (UK)
- Telehealth in Urology - Nephrologists 2025 (France)
- Telemedicine and Home Dialysis Advancements - Nephrology 2025 (France)
- The End Stage Renal Diseases & Chronic Kidney Diseases - Kidney Care 2026 (UK)
- The Neuroimmune Interface in Autoimmune Diseases - Neuropharmacology 2025 (Italy)
- The Role of AI in Nephrology - Nephrologists 2025 (France)
- Understanding Glomerular Diseases - Nephrologists 2025 (France)
- Urological Emergencies: Quick Response - Nephrologists 2025 (France)
- Urological Oncology: Current Trends - Nephrologists 2025 (France)
- Urology - KIDNEY MEET 2025 (UK)
- Urology / Urinary Tract Infections - Kidney Care 2026 (UK)
- Urology and Kidney Stone Management - Nephrology 2025 (France)
- Urology and Sexual Health - Nephrologists 2025 (France)
- Viral Infections and Neuroimmune Responses - Neuropharmacology 2025 (Italy)
- Women Health and Pregnancy - KIDNEY MEET 2025 (UK)
- Women’s Health and Kidney Disorders - Nephrology 2025 (France)